Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1995 1
1996 1
2000 1
2004 1
2005 6
2006 3
2007 1
2008 7
2009 7
2010 3
2011 4
2012 3
2013 11
2014 3
2015 4
2016 6
2017 6
2018 6
2019 5
2020 8
2021 5
2022 10
2023 1
2024 4
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
Redmer T, Raigel M, Sternberg C, Ziegler R, Probst C, Lindner D, Aufinger A, Limberger T, Trachtova K, Kodajova P, Högler S, Schlederer M, Stoiber S, Oberhuber M, Bolis M, Neubauer HA, Miranda S, Tomberger M, Harbusch NS, Garces de Los Fayos Alonso I, Sternberg F, Moriggl R, Theurillat JP, Tichy B, Bystry V, Persson JL, Mathas S, Aberger F, Strobl B, Pospisilova S, Merkel O, Egger G, Lagger S, Kenner L. Redmer T, et al. Among authors: persson jl. Mol Cancer. 2024 May 29;23(1):114. doi: 10.1186/s12943-024-02022-x. Mol Cancer. 2024. PMID: 38811984 Free PMC article.
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment.
Sternberg C, Raigel M, Limberger T, Trachtová K, Schlederer M, Lindner D, Kodajova P, Yang J, Ziegler R, Kalla J, Stoiber S, Dey S, Zwolanek D, Neubauer HA, Oberhuber M, Redmer T, Hejret V, Tichy B, Tomberger M, Harbusch NS, Pencik J, Tangermann S, Bystry V, Persson JL, Egger G, Pospisilova S, Eferl R, Wolf P, Sternberg F, Högler S, Lagger S, Rose-John S, Kenner L. Sternberg C, et al. Among authors: persson jl. Mol Cancer. 2024 Oct 31;23(1):245. doi: 10.1186/s12943-024-02114-8. Mol Cancer. 2024. PMID: 39482716 Free PMC article.
SATB1 in Malignant T Cells.
Fredholm S, Willerslev-Olsen A, Met Ö, Kubat L, Gluud M, Mathiasen SL, Friese C, Blümel E, Petersen DL, Hu T, Nastasi C, Lindahl LM, Buus TB, Krejsgaard T, Wasik MA, Kopp KL, Koralov SB, Persson JL, Bonefeld CM, Geisler C, Woetmann A, Iversen L, Becker JC, Ødum N. Fredholm S, et al. Among authors: persson jl. J Invest Dermatol. 2018 Aug;138(8):1805-1815. doi: 10.1016/j.jid.2018.03.1526. Epub 2018 May 8. J Invest Dermatol. 2018. PMID: 29751003 Free article.
Epitranscriptomic mechanisms of androgen signalling and prostate cancer.
Patke R, Harris AE, Woodcock CL, Thompson R, Santos R, Kumari A, Allegrucci C, Archer N, Gudas LJ, Robinson BD, Persson JL, Fray R, Jeyapalan J, Rutland CS, Rakha E, Madhusudan S, Emes RD, Muyangwa-Semenova M, Alsaleem M, de Brot S, Green W, Ratan H, Mongan NP, Lothion-Roy J. Patke R, et al. Among authors: persson jl. Neoplasia. 2024 Oct;56:101032. doi: 10.1016/j.neo.2024.101032. Epub 2024 Jul 20. Neoplasia. 2024. PMID: 39033689 Free PMC article. Review.
Comparative pathology of dog and human prostate cancer.
Ryman-Tubb T, Lothion-Roy JH, Metzler VM, Harris AE, Robinson BD, Rizvanov AA, Jeyapalan JN, James VH, England G, Rutland CS, Persson JL, Kenner L, Rubin MA, Mongan NP, de Brot S. Ryman-Tubb T, et al. Among authors: persson jl. Vet Med Sci. 2022 Jan;8(1):110-120. doi: 10.1002/vms3.642. Epub 2021 Oct 10. Vet Med Sci. 2022. PMID: 34628719 Free PMC article. Review.
Regulation of vascular endothelial growth factor in prostate cancer.
de Brot S, Ntekim A, Cardenas R, James V, Allegrucci C, Heery DM, Bates DO, Ødum N, Persson JL, Mongan NP. de Brot S, et al. Among authors: persson jl. Endocr Relat Cancer. 2015 Jun;22(3):R107-23. doi: 10.1530/ERC-15-0123. Epub 2015 Apr 13. Endocr Relat Cancer. 2015. PMID: 25870249 Review.
Single-cell heterogeneity in Sézary syndrome.
Buus TB, Willerslev-Olsen A, Fredholm S, Blümel E, Nastasi C, Gluud M, Hu T, Lindahl LM, Iversen L, Fogh H, Gniadecki R, Litvinov IV, Persson JL, Bonefeld CM, Geisler C, Christensen JP, Krejsgaard T, Litman T, Woetmann A, Ødum N. Buus TB, et al. Among authors: persson jl. Blood Adv. 2018 Aug 28;2(16):2115-2126. doi: 10.1182/bloodadvances.2018022608. Blood Adv. 2018. PMID: 30139925 Free PMC article.
Cancer therapy: targeting cell cycle regulators.
Johansson M, Persson JL. Johansson M, et al. Among authors: persson jl. Anticancer Agents Med Chem. 2008 Oct;8(7):723-31. doi: 10.2174/187152008785914833. Anticancer Agents Med Chem. 2008. PMID: 18855574 Review.
A 23-Gene Classifier urine test for prostate cancer prognosis.
Guo J, Johnson H, Zhang X, Feng X, Zhang H, Simoulis A, Wu AH, Xia T, Li F, Tan W, Johnson A, Dizeyi N, Abrahamsson PA, Kenner L, Chen L, Zhong W, Xiao K, Persson JL, Zou C. Guo J, et al. Among authors: persson jl. Clin Transl Med. 2021 Mar;11(3):e340. doi: 10.1002/ctm2.340. Clin Transl Med. 2021. PMID: 33784002 Free PMC article. No abstract available.
99 results